Search

Your search keyword '"Catala M"' showing total 506 results
Start Over Author "Catala M"
506 results on '"Catala M"'

17. Multisystem inflammatory syndrome in children in western countries: decreasing incidence as the pandemic progresses? An observational multicenter international cross-sectional study

Author

Buonsenso, D., Perramon, A., Catala, M., Torres, J.P., Camacho-Moreno, G., Rojas-Solano, M., Ulloa-Gutierrez, R., Camacho-Badilla, K., Perez-Corrales, C., Cotugno, N., Yamazaki-Nakashimada, M.A., Estripeaut, D., Buddingh, E.P., Asmuth, E. von, Rossum, A.M.C. van, Soler-Palacin, P., Riviere, J.G., Prats, C., Pino, R., Paredes-Carmona, F., Visa-Rene, N., Garcia-Salido, A., Martinez-Mejias, A., Soriano-Arandes, A., COPEDI-CAT Res Grp, Universitat Politècnica de Catalunya. Doctorat en Física Computacional i Aplicada, Universitat Politècnica de Catalunya. Departament de Física, Universitat Politècnica de Catalunya. BIOCOM-SC - Biologia Computacional i Sistemes Complexos, Medical Microbiology & Infectious Diseases, and Pediatrics

Subjects
Microbiology (medical), COVID-19 Vaccines, SARS-CoV-2, COVID-19, Infeccions respiratòries, Settore MED/38, Systemic Inflammatory Response Syndrome, COVID-19--nursing, Cross-Sectional Studies, Infectious Diseases, children, SDG 3 - Good Health and Well-being, multisystemic inflammatory syndrome in children, Pediatrics, Perinatology and Child Health, Ciències de la salut::Medicina::Medicina comunitària i salut pública [Àrees temàtiques de la UPC], incidence, Humans, epidemiology, Child, Covid-19, Pandemics
Abstract

BACKGROUND: SARS-CoV-2 variations as well as immune protection after previous infections and/or vaccination may have altered the incidence of multisystemic inflammatory syndrome in children (MIS-C). We aimed to report an international time-series analysis of the incidence of MIS-C to determine if there was a shift in the regions or countries included into the study. METHODS: This is a multicenter, international, cross-sectional study. We collected the MIS-C incidence from the participant regions and countries for the period July 2020 to November 2021. We assessed the ratio between MIS-C cases and COVID-19 pediatric cases in children

Published
2022

18. Neural Stem Cells

Author

Kubis, N., Catala, M., HAL-UPMC, Gestionnaire, Durand C. et Charbord P. (Eds.), Morphogénèse du Cerveau des Vertébrés = Morphogenesis of the vertebrate brain (LBD-E10), Laboratoire de Biologie du Développement (LBD), Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Paris Seine (IBPS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Paris Seine (IBPS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Biologie Paris Seine (IBPS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Biologie Paris Seine (IBPS), and Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
[SDV.BC]Life Sciences [q-bio]/Cellular Biology, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2022

20. A multidisciplinary program based on early follow-up in a day hospital after heart failure hospitalizations. Reduction of 30-day readmissions in a population analysis over a 6-year period

Author

Vaqueriza Cubillo, D, primary, Beltran Herrera, C, additional, Dominguez Munoa, M, additional, Suberviola Sanchez-Caballero, V, additional, Gomez Mariscal, E, additional, Briongos Figuero, S, additional, Estevez Paniagua, A, additional, Sanchez Hernandez, A, additional, Cortina Camarero, C, additional, Sarrion Catala, M, additional, Jimenez Loeches, S, additional, Mora Yague, L, additional, Giganto Arroyo, M L, additional, Cano Moracho, J M, additional, and Munoz Aguilera, R, additional

Published
2022
Full Text
View/download PDF

21. List of contributors

Author

Acién, F.G., primary, Agudo, L., additional, Aires-Barros, M.R., additional, Alcántara, C., additional, Amaro, H.M., additional, Arbib, Z., additional, Barbosa, M., additional, Bastiaens, L., additional, Bazaes, J., additional, Béchet, Q., additional, Bolado, S., additional, Bruno, L., additional, Buitrón, G., additional, Carrillo-Reyes, J., additional, Catala, M., additional, Cavinato, C., additional, Čelešnik, H., additional, Chambonnière, P., additional, Congestri, R., additional, Coronado, J.M., additional, D’Hondt, E., additional, de Godos, I., additional, Deniz, I., additional, Dolinar, M., additional, Elst, K., additional, Ertekin, F., additional, Faraloni, C., additional, Fermoso, J., additional, Fernandes, B., additional, Fernández-Sevilla, J.M., additional, Filho, N.R.A., additional, Fischer, F., additional, Frigaard, N.-U., additional, García-Encina, P.A., additional, García-Vaquero, M., additional, Geada, P., additional, Gkelis, S., additional, Gonzalez-Fernandez, C., additional, Gouveia, L., additional, Gudmundsson, S., additional, Guedes, A. Catarina, additional, Guieysse, B., additional, Hayes, M., additional, Imamoglu, E., additional, Isleten Hosoglu, M., additional, Jensen, P.E., additional, Kasperoviciene, J., additional, Kendir, E., additional, Klemenčič, M., additional, Koc, M., additional, Koreiviene, J., additional, Lebrero, R., additional, Lorenzo-Hernando, A., additional, Malcata, F.X., additional, Markou, G., additional, Martín-Juárez, J., additional, Masojídek, J., additional, Mazur-Marzec, H., additional, Menezes, R.S., additional, Molina, E., additional, Morales, M., additional, Muñoz, R., additional, Muylaert, K., additional, Nielsen, A.Z., additional, Nobre, B.P., additional, Nogales, J., additional, Norvill, Z., additional, Oancea, F., additional, Oliveira, A.C., additional, Palavra, A.M.F., additional, Pizarro, P., additional, Plouviez, M., additional, Posadas, E., additional, Reis, A., additional, Sakuragi, Y., additional, Sepúlveda, C., additional, Serrano, D.P., additional, Skjånes, K., additional, Skomedal, H., additional, Soares, A.T., additional, Sousa-Pinto, I., additional, Sulcius, S., additional, Teixeira, J., additional, Thomassen, G., additional, Toledo-Cervantes, A., additional, Toruńska-Sitarz, A., additional, Torzillo, G., additional, Tzovenis, I., additional, Ugurlu, A., additional, van Roy, S., additional, Vandamme, D., additional, Vasconcelos, V., additional, Velea, S., additional, Ventura, S.P.M, additional, Vicente, A.A., additional, Vieira, F., additional, and Zittelli, G.C., additional

Published
2017
Full Text
View/download PDF

22. Microalgal proteins for feed, food and health

Author

Hayes, M., primary, Skomedal, H., additional, Skjånes, K., additional, Mazur-Marzec, H., additional, Toruńska-Sitarz, A., additional, Catala, M., additional, Isleten Hosoglu, M., additional, and García-Vaquero, M., additional

Published
2017
Full Text
View/download PDF

24. Hepatitis C Virus positivity prediction from serum samples using NIRS and L1-penalized classification

Author

Barquero-Perez, O., primary, Gomez-Sanchez, J., additional, Riado-Minguez, D., additional, Gonzalo-Segovia, J., additional, Garcia-Carretero, R., additional, Casas-Losada, ML., additional, Fernandez-Rodriguez, S., additional, Gutierrez-Garcia, ML., additional, Jaime-Lara, E., additional, Perez-Martinez, E., additional, Ramos-Lopez, J., additional, Salguero-Fernandez, S., additional, Fernandez-Rodriguez, C., additional, and Catala, M., additional

Published
2022
Full Text
View/download PDF

26. Mediterranean Diet Adherence in Individuals with Prediabetes and Unknown Diabetes : The Di@bet.es Study

Author

Ortega, E., Franch, J., Castell, C., Goday, A., Ribas-Barba, L., Soriguer, F., Vendrell, J., Casamitjana, R., Bosch-Comas, A., Bordiú, E., Calle-Pascual, A., Carmena, R., Castaño, L., Catalá, M., Delgado, E., Gaztambide, S., Girbés, J., López-Alba, A., Martínez-Larrad, M.T., Menéndez, E., Mora-Peces, I., Pascual-Manich, G., Rojo-Martínez, G., Serrano-Rios, M., Urrutía, I., Valdés, S., Vázquez, J. A., and Gomis, R.

Published
2013

28. Iodine intake in the adult population. Di@bet.es study

Author

Soriguer, F., García-Fuentes, E., Gutierrez-Repiso, C., Rojo-Martínez, G., Velasco, I., Goday, A., Bosch-Comas, A., Bordiú, E., Calle, A., Carmena, R., Casamitjana, R., Castaño, L., Castell, C., Catalá, M., Delgado, E., Franch, J., Gaztambide, S., Girbés, J., Gomis, R., Gutiérrez, G., López-Alba, A., Martínez-Larrad, M.T., Menéndez, E., Mora-Peces, I., Ortega, E., Pascual-Manich, G., Serrano-Rios, M., Valdés, S., Vázquez, J.A., and Vendrell, J.

Published
2012
Full Text
View/download PDF

31. A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia

Author

Lopez, F, Catala, M, Prats, C, Estrada, O, Oliva, I, Prat, N, Isnard, M, Valles, R, Vilar, M, Clotet, B, Argimon, JM, Aran, A, and Ara, J

Subjects
pharmacoeconomics, cost-benefit analysis, COVID-19, health economics, vaccination, economic appraisal
Abstract

(1) Background: In epidemiological terms, it has been possible to calculate the savings in health resources and the reduction in the health effects of COVID vaccines. Conducting an economic evaluation, some studies have estimated its cost-effectiveness; the vaccination shows highly favorable results, cost-saving in some cases. (2) Methods: Cost-benefit analysis of the vaccination campaign in the North Metropolitan Health Region (Catalonia). An epidemiological model based on observational data and before and after comparison is used. The information on the doses used and the assigned resources (conventional hospital beds, ICU, number of tests) was extracted from administrative data from the largest primary care provider in the region (Catalan Institute of Health). A distinction was made between the social perspective and the health system. (3) Results: the costs of vaccination are estimated at 137 million euros (euro48.05/dose administered). This figure is significantly lower than the positive impacts of the vaccination campaign, which are estimated at 470 million euros (euro164/dose administered). Of these, 18% corresponds to the reduction in ICU discharges, 16% to the reduction in conventional hospital discharges, 5% to the reduction in PCR tests and 1% to the reduction in RAT tests. The monetization of deaths and cases that avoid sequelae account for 53% and 5% of total savings, respectively. The benefit/cost ratio is estimated at 3.4 from a social perspective and 1.4 from a health system perspective. The social benefits of vaccination are estimated at euro116.67 per vaccine dose (euro19.93 from the perspective of the health system). (4) Conclusions: The mass vaccination campaign against COVID is cost-saving. From a social perspective, most of these savings come from the monetization of the reduction in mortality and cases with sequelae, although the intervention is equally widely cost-effective from the health system perspective thanks to the reduction in the use of resources. It is concluded that, from an economic perspective, the vaccination campaign has high social returns.

Published
2022

37. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

Author

Soriguer, F., Rojo-Martinez, G., Goday, A., Bosch-Comas, A., Bordiu, E., Caballero-Diaz, F., Calle-Pascual, A., Carmena, R., Casamitjana, R., Castano, L., Castell, C., Catala, M., Delgado, E., Franch, J., Gaztambide, S., Girbes, J., Gomis, R., Gutierrez, G., Lopez-Alba, A., Martinez-Larrad, M. Teresa, Menendez, E., Mora-Peces, I., Ortega, E., Pascual-Manich, G., Serrano-Rios, M., Urrutia, I., Valdes, S., Vazquez, J. Antonio, and Vendrell, J.

Subjects
Olive oil -- Health aspects, Diabetes -- Physiological aspects -- Risk factors, Glucose metabolism -- Research, Food/cooking/nutrition, Health
Abstract

BACKGROUND: Despite the marked increase in cardiovascular risk factors in Spain in recent years, the prevalence and incidence of cardiovascular diseases have not risen as expected. Our objective is to examine the association between consumption of olive oil and the presence of cardiometabolic risk factors in the context of a large study representative of the Spanish population. SUBJECTS AND METHODS: A population-based, cross-sectional, cluster sampling study was conducted. The target population was the whole Spanish population. A total of 4572 individuals aged ≥ 18 years in 100 clusters (health centers) were randomly selected with a probability proportional to population size. The main outcome measures were clinical and demographic structured survey, lifestyle survey, physical examination (weight, height, body mass index, waist, hip and blood pressure) and oral glucose tolerance test (OGTT) (75 g). RESULTS: Around 90% of the Spanish population use olive oil, at least for dressing, and slightly fewer for cooking or frying. The preference for olive oil is related to age, educational level, alcohol intake, body mass index and serum glucose, insulin and lipids. People who consume olive oil (vs sunflower oil) had a lower risk of obesity (odds ratio (OR) = 0.62 (95% confidence interval (CI) = 0.41-0.93, P = 0.02)), impaired glucose regulation (OR = 0.49 (95% CI = 0.28-0.86, P = 0.04)), hypertriglyceridemia (OR = 0.53 (95% CI = 0.33-0.84, P = 0.03)) and low HDL cholesterol levels (OR = 0.40 (95% CI = 0.26-0.59, P = 0.0001)). CONCLUSIONS: The results show that consumption of olive oil has a beneficial effect on different cardiovascular risk factors, particularly in the presence of obesity, impaired glucose tolerance or a sedentary lifestyle. European Journal of Clinical Nutrition (2013) 67, 911-916; doi:10.1038/ejcn.2013.130; published online 17 July 2013 Keywords: olive oil; diabetes; impaired glucose regulation; obesity; population-based study; cardiovascular risk, INTRODUCTION The high rates of morbidity and mortality due to cardiovascular diseases represent one of the greatest social and health care problems in developed countries, as well as in many [...]

Published
2013
Full Text
View/download PDF

41. Interaction of both positive and negative daily-life experiences with FKBP5 haplotype on psychosis risk

Author

Cristóbal-Narváez P, Sheinbaum T, Rosa A, de Castro-Catala M, Domínguez-Martínez T, Kwapil TR, and Barrantes-Vidal N

Subjects
Gene–environment interaction, ecological validity, experience sampling methodology, incipient psychosis, vantage sensitivity
Abstract

There is limited research on the interaction of both positive and negative daily-life environments with stress-related genetic variants on psychotic experiences (PEs) and negative affect (NA) across the extended psychosis phenotype. This study examined whether the FK506 binding protein 51 (FKBP5) variability moderates the association of positive and negative experiences in the moment with PEs and NA in participants with incipient psychosis and their nonclinical counterparts.

Published
2020

45. FROM THE SPINAL CORD TO THE MUSCLE

Author

Querin, G., primary, Bede, P., additional, Mendili, M. El, additional, Péllegrini-Issac, M., additional, Rinaldi, D., additional, Catala, M., additional, Saracino, D., additional, Salachas, F., additional, Camuzat, A., additional, Marchand-Pauvert, V., additional, Cohen-Adad, J., additional, Colliot, O., additional, Ber, I. Le, additional, Pradat, P., additional, and Study Group, PREV-DEMALS, additional

Published
2020
Full Text
View/download PDF

47. RNase M5 bound to 50S ribosome with precursor 5S rRNA

Author

Oerum, S., primary, Dendooven, T., additional, Gilet, L., additional, Catala, M., additional, Degut, C., additional, Trinquier, A., additional, Barraud, P., additional, Luisi, B., additional, Condon, C., additional, and Tisne, C., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results